ORIC Pharmaceuticals Inc (NASDAQ:ORIC)’s traded shares stood at 0.88 million during the last session, with the company’s beta value hitting 1.19. At the close of trading, the stock’s price was $12.25, to imply a decrease of -2.31% or -$0.29 in intraday trading. The ORIC share’s 52-week high remains $16.65, putting it -35.92% down since that peak but still an impressive 48.33% since price per share fell to its 52-week low of $6.33. The company has a valuation of $864.45M, with an average of 1.1 million shares in intraday trading volume over the past 10 days and average of 556.98K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for ORIC Pharmaceuticals Inc (ORIC), translating to a mean rating of 1.08. Of 5 analyst(s) looking at the stock, 0 analyst(s) give ORIC a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC) trade information
After registering a -2.31% downside in the last session, ORIC Pharmaceuticals Inc (ORIC) has traded red over the past five days. The 5-day price performance for the stock is 17.56%, and 32.86% over 30 days. With these gigs, the year-to-date price performance is 51.80%. Short interest in ORIC Pharmaceuticals Inc (NASDAQ:ORIC) saw shorts transact 10.52 million shares and set a 17.67 days time to cover.
The extremes give us $20 and $20 for target low and target high price respectively. As such, ORIC has been trading -63.27% off suggested target high and -63.27% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -22.33% for the past 5-year period. While 2025 is set for a 5.14% return in earnings, projections for the next 5 years are at -2.58% annually.
ORIC Dividends
ORIC Pharmaceuticals Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
ORIC Pharmaceuticals Inc (NASDAQ:ORIC)’s Major holders
ORIC Pharmaceuticals Inc insiders hold 9.50% of total outstanding shares, with institutional holders owning 102.25% of the shares at 112.98% float percentage. In total, 102.25% institutions holds shares in the company, led by NEXTECH INVEST LTD.. As of 2024-06-30, the company held over 5.29 million shares (or 7.8482% of shares), all amounting to roughly $37.37 million.
The next major institution holding the largest number of shares is FMR LLC with 4.92 million shares, or about 7.3057% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $34.79 million.
We also have ACAP Strategic Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the ORIC Pharmaceuticals Inc (ORIC) shares. Going by data provided on Sep 30, 2024 , ACAP Strategic Fund holds roughly 1.92 shares. This is just over 2.72% of the total shares, with a market valuation of $23.52 million. Data from the same date shows that the other fund manager holds a little less at 1.88, or 2.66% of the shares, all valued at about 23.04 million.
